Waters Corporation Share Price London S.E.

Equities

0LTI

US9418481035

Advanced Medical Equipment & Technology

Market Closed - London S.E. 15:19:45 07/05/2024 BST 5-day change 1st Jan Change
316.3 USD +1.08% Intraday chart for Waters Corporation -2.30% -3.68%
Sales 2024 * 2.97B 237B Sales 2025 * 3.15B 252B Capitalization 20.83B 1,664B
Net income 2024 * 637M 50.88B Net income 2025 * 719M 57.43B EV / Sales 2024 * 7.46 x
Net Debt 2024 * 1.31B 105B Net Debt 2025 * 1.1B 87.67B EV / Sales 2025 * 6.96 x
P/E ratio 2024 *
32.5 x
P/E ratio 2025 *
28.6 x
Employees 7,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.08%
1 week-2.30%
Current month+2.10%
1 month-7.27%
3 months-2.57%
6 months+24.63%
Current year-3.68%
More quotes
1 week
316.26
Extreme 316.26
347.30
1 month
292.92
Extreme 292.92
347.30
Current year
292.92
Extreme 292.92
364.14
1 year
232.01
Extreme 232.01
364.14
3 years
232.01
Extreme 232.01
425.84
5 years
164.20
Extreme 164.2
425.84
10 years
164.20
Extreme 164.2
425.84
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 31/08/20
Director of Finance/CFO 48 11/05/21
Chief Operating Officer - 31/12/21
Members of the board TitleAgeSince
Director/Board Member 65 31/08/18
Director/Board Member 68 26/03/23
Director/Board Member 70 30/04/06
More insiders
Date Price Change Volume
10/05/24 343.8 +2.32% 31
09/05/24 336 +2.99% 16
08/05/24 326.3 +1.41% 444
07/05/24 321.7 -0.57% 501
06/05/24 323.6 -0.05% 198

Delayed Quote London S.E., May 07, 2024 at 03:19 pm

More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
351.1 USD
Average target price
324.4 USD
Spread / Average Target
-7.61%
Consensus